EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody

Mohammad E Khosroshahi iD, Yesha Patel, Vithurshan Umashanker

Sensors · 20.08.2024 · 24 (16) · 5378

DOI: 10.3390/s24165378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sensors, online erschienen am 20.08.2024. Verfasst von Mohammad E Khosroshahi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nanobiophotonics & Biomedical Research Laboratory, M.I.S. Electronics Inc., Richmond Hill, ON L4B 1B4, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Gold, Biomarkers, Tumor, Spectrum Analysis, Raman. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIS Electronics Inc., MIS Electronics Inc., Department of R&D.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work describes our recent PCB-based plasmonic nanostructured platform patent (US 11,828,747B2) for the detection of biomarkers in breast cancer serum (BCS). A 50 nm thin gold film (TGF) was immersion-coated on PCB (i.e., PCB-TGF) and immobilized covalently with gold nanourchin (GNU) via a 1,6-Hexanedithiol (HDT) linkage to produce a plasmonic activated nanostructured thin film (PANTF) platform. A label-free SERS immunosensor was fabricated by conjugating the platform with monoclonal HER-II antibodies (mAb) in a directional orientation via adipic acid dihydrazide (ADH) to provide higher accessibility to overexpressed HER-II biomarkers (i.e., 2+ (early), 3+ (locally advanced), and positive (meta) in BCS. An enhancement factor (EF) of 0.3 × 105 was achieved for PANTF using Rhodamine (R6G), and the morphology was studied by scanning electron microscopy (SEM) and atomic force microscope (AFM). UV-vis spectroscopy showed the peaks at 222, 231, and 213 nm corresponding to ADH, mAb, and HER-II biomarkers, respectively. The functionalization and conjugation were investigated by Fourier Transform Near Infrared (FT-NIR) where the most dominant overlapped spectra of 2+, 3+, and Pos correspond to OH-combination of carbohydrate, RNH2 1st overtone, and aromatic CH 1st overtone of mAb, respectively. SERS data were filtered using the filtfilt filter from scipy.signals, baseline corrected using the Improved Asymmetric Least Squares (isals) function from the pybaselines.Whittaker library. The results showed the common peaks at 867, 1312, 2894, 3026, and 3258 cm−1 corresponding to glycine, alanine ν (C-N-C) assigned to the symmetric C-N-C stretch mode; tryptophan and α helix; C-H antisymmetric and symmetric stretching; NH3+ in amino acids; and N-H stretch primary amide, respectively, with the intensity of Pos > 3+ > 2+. This trend is justifiable considering the stage of each sample. Principal Component Analysis (PCA) and Linear Discrimination Analysis (LDA) were employed for the statistical analysis of data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGoldBiomarkers, TumorSpectrum Analysis, RamanNanostructuresHumansFemaleBiosensing TechniquesErb-b2 Receptor Tyrosine KinasesMetal NanoparticlesAntibodies, ImmobilizedSpectroscopy, Fourier Transform InfraredImmunoassaySpectroscopy, Near-Infrared

Stichwörter der Autor:innen

SERSbiomarkerbreast cancerdirectional antibodygold nanourchinshuman serum

Substanzen

GoldBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesAntibodies, ImmobilizedERBB2 protein, human

Autor:innen und Institutionen

  • Nanobiophotonics & Biomedical Research Laboratory, M.I.S. Electronics Inc., Richmond Hill, ON L4B 1B4, Canada.
  • Institute for Advanced Non-Destructive and Non-Invasive Diagnostic Technologies (IANDIT), University of Toronto, Toronto, ON M5S 3G8, Canada.
  • Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON M5S 3G8, Canada.
  • Department of Biochemical Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
  • Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

ORCID-Profile: Mohammad E Khosroshahi

Förderung

  • MIS Electronics Inc.
  • MIS Electronics Inc., Department of R&D

Zitieren

APA

Khosroshahi, M. E., Patel, Y., & Umashanker, V. (2024). Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody. Sensors, 24(16), 5378. https://doi.org/10.3390/s24165378

Vancouver

Khosroshahi ME, Patel Y, Umashanker V. Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody. Sensors. 2024;24(16):5378. doi:10.3390/s24165378

BibTeX
@article{Khosroshahi2024,
  author = {Khosroshahi, Mohammad E and Patel, Yesha and Umashanker, Vithurshan},
  title = {Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody},
  journal = {Sensors},
  year = {2024},
  volume = {24},
  number = {16},
  pages = {5378},
  doi = {10.3390/s24165378}
}
Kostenlos starten →